Most of us have heard the dictum "the trend is your friend." And this is undeniably the key to success when it comes to short-term investing or trading. But it isn't easy to ensure the sustainability ...

LogiCare3PL is proud to support the commercial launch of VYKAT™ XR, Soleno Therapeutics' newly FDA-approved therapy and the first and only treatment indicated for hyperphagia in patients with ...

In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Soleno Therapeutics (SLNO – Research Report), with a ...

The U.S. FDA issued a complete response letter in October 2023 for Dupixent (dupilumab) in treating chronic hives but has now approved the monoclonal antibody for the indication. The approval makes ...

Soleno Therapeutics Inc. (NASDAQ:SLNO), a $3.2 billion market cap company specializing in electromedical and electrotherapeutic apparatus, announced a change in its independent registered public ...

Soleno Therapeutics Inc. (NASDAQ:SLNO), a $3.2 billion market cap company specializing in electromedical and electrotherapeutic apparatus, announced a change in its independent registered public ...